Prevalence of gestational diabetes mellitus in Kashmiri women from the Indian subcontinent

被引:71
作者
Zargar, AH [1 ]
Sheikh, MI [1 ]
Bashir, MI [1 ]
Masoodi, SR [1 ]
Laway, BA [1 ]
Wani, AI [1 ]
Bhat, MH [1 ]
Dar, FA [1 ]
机构
[1] Sher & Kashmir Inst Med Sci, Dept Endocrinol, Kashmir 190001, India
关键词
gestational diabetes mellitus; glucose challenge test; glucose tolerance test; prevalence;
D O I
10.1016/j.diabres.2004.02.023
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This prospective study was carried out to determine the prevalence of gestational diabetes mellitus (GDM) in Kashmiri women and to assess the effect of various demographic factors. Two thousand pregnant women (divided into groups A and B, being the first and last 1000 consecutive women) attending various antenatal clinics in six districts of Kashmir valley were screened for GDM by 1 h 50 g oral glucose challenge test. Four hundred and fourteen (20.8%) women (216 from group A and 198 from group B) had an abnormal screening test and proceeded to oral glucose tolerance testing. Women from group A had a 3 h 100 gram oral glucose tolerance test (OGTT) and GDM was as classified by Carpenter and Coustan. A 2 h 75 g OGTT was performed on group B subjects and WHO criteria applied for diagnosis of GDM. The overall prevalence of GDM was 3.8% (3.1% in group A versus 4.4% in group B-P-value 0.071). GDM prevalence steadily increased with age (from 1.7% in women below 25 years to 18% in women 35 years or older). GDM occurred more frequently in women who were residing in urban areas, had borne three or more children, had history of abortion(s) or GDM during previous pregnancies, had given birth to a macrosomic baby, or had a family history of diabetes mellitus. Women with obesity, hypertension, osmotic symptoms, proteinuria or hydramnios had a higher prevalence of GDM. (C) 2004 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:139 / 145
页数:7
相关论文
共 38 条
[1]  
American Diabetes Association, 2002, DIABETES CARE S1, V25, pS94, DOI [DOI 10.2337/DIACARE.25.2007.S94), 10.2337/diacare.25.2007.S94, DOI 10.2337/DIACARE.25.2007.S94]
[2]  
[Anonymous], DEF DIAGN CLASS DIAB
[3]  
Bowes SB, 1996, DIABETOLOGIA, V39, P976
[4]   CRITERIA FOR SCREENING-TESTS FOR GESTATIONAL DIABETES [J].
CARPENTER, MW ;
COUSTAN, DR .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1982, 144 (07) :768-773
[5]   INCIDENCE AND SIGNIFICANCE OF ISLET CELL ANTIBODIES IN WOMEN WITH PREVIOUS GESTATIONAL DIABETES [J].
CATALANO, PM ;
TYZBIR, ED ;
SIMS, EAH .
DIABETES CARE, 1990, 13 (05) :478-482
[6]   RELATIONSHIP OF FETAL MACROSOMIA TO MATERNAL POSTPRANDIAL GLUCOSE CONTROL DURING PREGNANCY [J].
COMBS, CA ;
GUNDERSON, E ;
KITZMILLER, JL ;
GAVIN, LA ;
MAIN, EK .
DIABETES CARE, 1992, 15 (10) :1251-1257
[7]   INSULIN THERAPY FOR GESTATIONAL DIABETES [J].
COUSTAN, DR ;
LEWIS, SB .
OBSTETRICS AND GYNECOLOGY, 1978, 51 (03) :306-310
[8]   PREDICTIVE FACTORS FOR THE DEVELOPMENT OF DIABETES IN WOMEN WITH PREVIOUS GESTATIONAL DIABETES-MELLITUS [J].
DAMM, P ;
KUHL, C ;
BERTELSEN, A ;
MOLSTEDPEDERSEN, L .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1992, 167 (03) :607-616
[9]  
Deerochanawong C, 1996, DIABETOLOGIA, V39, P1070
[10]   POSTPRANDIAL VERSUS PREPRANDIAL BLOOD-GLUCOSE MONITORING IN WOMAN WITH GESTATIONAL DIABETES-MELLITUS REQUIRING INSULIN THERAPY [J].
DEVECIANA, M ;
MAJOR, CA ;
MORGAN, MA ;
ASRAT, T ;
TOOHEY, JS ;
LIEN, JM ;
EVANS, AT .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (19) :1237-1241